Results
|
|
21.
|
|
|
|
22.
|
|
|
|
23.
|
|
|
|
24.
|
|
|
|
25.
|
|
|
|
26.
|
|
|
|
27.
|
|
|
|
28.
|
|
|
|
29.
|
|
|
|
30.
|
New mustard prodrugs for antibody-directed enzyme prodrug therapy: alternatives to the amide link. [electronic resource] by
- Dowell, R I
- Springer, C J
- Davies, D H
- Hadley, E M
- Burke, P J
- Boyle, F T
- Melton, R G
- Connors, T A
- Blakey, D C
- Mauger, A B
Producer: 19960815
In:
Journal of medicinal chemistry vol. 39
Availability: No items available.
|
|
|
31.
|
Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. [electronic resource] by
- Robinson, S P
- McIntyre, D J O
- Checkley, D
- Tessier, J J
- Howe, F A
- Griffiths, J R
- Ashton, S E
- Ryan, A J
- Blakey, D C
- Waterton, J C
Producer: 20030626
In:
British journal of cancer vol. 88
Availability: No items available.
|
|
|
32.
|
ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenografts. [electronic resource] by
- Blakey, D C
- Burke, P J
- Davies, D H
- Dowell, R I
- East, S J
- Eckersley, K P
- Fitton, J E
- McDaid, J
- Melton, R G
- Niculescu-Duvaz, I A
- Pinder, P E
- Sharma, S K
- Wright, A F
- Springer, C J
Producer: 19960920
In:
Cancer research vol. 56
Availability: No items available.
|
|
|
33.
|
A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo. [electronic resource] by
- Eberlein, C
- Kendrew, J
- McDaid, K
- Alfred, A
- Kang, J S
- Jacobs, V N
- Ross, S J
- Rooney, C
- Smith, N R
- Rinkenberger, J
- Cao, A
- Churchman, A
- Marshall, J F
- Weir, H M
- Bedian, V
- Blakey, D C
- Foltz, I N
- Barry, S T
Producer: 20131108
In:
Oncogene vol. 32
Availability: No items available.
|